logo

For the Inventor, By the Inventor

Chesterfield, MO, United States of America

Donald J Rogier

This inventor holds 19 USPTO granted patents, primarily in Pharmaceutical Chemistry. Top assignees: G.d. Searle & Company, Pfizer Corporation, Pharmacia & Upjohn Company. Active years: 1996-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Donald J Rogier. Retrieved from https://idiyas.com/inventor/donald-j-rogier

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 19

% Patents Active = 63.2

Average Co-Inventor Count = 7.3

ph-index = 8

Forward Citations = 277(Granted Patents)


Location History:

  • Kalamazoo, MI (US) (2003 - 2005)
  • Chesterfield, MO (US) (1996 - 2015)

Company Filing History:

goldMedal10 out of 1,323 
 
G.d. Searle & Company
 patents
silverMedal4 out of 4,488 
 
Pfizer Corporation
 patents
bronzeMedal2 out of 523 
 
Pharmacia & Upjohn Company
 patents
4. 1 out of 220 
 
Pharmacia Corporation
 patents
5. 1 out of 5 
 
Pharmacia Corporation (of Pfizer, Inc.)
 patents
6. 1 out of 834,570 
Other
 patents

Years Active: 1996-2015

Loading Chart...
Areas of Expertise:
Chemokine Receptor Agonists
Benzopyran Derivatives
Inflammation Treatment
Prodrugs
Azepino Derivatives
Heteroarylpyranopyrazolyl
Oxazoles
Pyrazolyl Derivatives
19 patents (USPTO):Explore Patents
1. 8946413 - 3-aminocyclopentanecarboxamides as chemokine receptor agonists (2015-02-03),
2. 8293903 - 3-aminocyclopentanecarboxamides as chemokine receptor agonists (2012-10-23),
3. 7138411 - Substituted benzopyran derivatives for the treatment of inflammation (2006-11-21),
4. 7109211 - Substituted benzopyran derivatives for the treatment of inflammation (2006-09-19),
5. 6903090 - Substituted azepino[4,5b]indole derivatives (2005-06-07),
6. 6828314 - Substituted azepino[4,5b]indoline derivatives (2004-12-07),
7. 6586421 - Substituted azepino[4,5b]indoline derivatives (2003-07-01),
8. 6583135 - Substituted azepino[4,5b]indole derivatives (2003-06-24),
9. 6492390 - Substituted benzopyran analogs for the treatment of inflammation (2002-12-10),
10. 6436967 - Process for preparing prodrugs of benzenesulfonamide-containing cox-2 inhibitors (2002-08-20),
11. 6271253 - Substituted benzopyran derivatives for the treatment of inflammation (2001-08-07),
12. 6090834 - Substituted oxazoles for the treatment of inflammation (2000-07-18),
13. 6077850 - Substituted benzopyran analogs for the treatment of inflammation (2000-06-20),
14. 6034256 - Substituted benzopyran derivatives for the treatment of inflammation (2000-03-07),
15. 5932598 - Prodrugs of benzenesulfonamide-containing COX-2 inhibitors (1999-08-03),

Title: Donald J Rogier - Innovative Inventor from Chesterfield, MO

Introduction: Donald J Rogier is a renowned inventor based in Chesterfield, Missouri, known for his groundbreaking contributions to various industries through his innovative creations.

Latest Patents: Donald J Rogier holds several patents in the fields of technology, healthcare, and consumer products, showcasing his diverse range of expertise and creativity.

Career Highlights: With a career spanning over two decades, Donald J Rogier has consistently pushed the boundaries of innovation, with his inventions revolutionizing the way we interact with everyday products and services.

Collaborations: Throughout his career, Donald J Rogier has collaborated with leading companies, research institutions, and universities to bring his ideas to life, further solidifying his reputation as a visionary inventor.

Conclusion: Donald J Rogier's passion for innovation and his relentless pursuit of excellence have established him as a prominent figure in the world of inventors, with his work continuing to inspire future generations of innovators.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…